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Abstract Lemierre’s syndrome is an often un-diagnosed
disease seen in previously healthy young subjects, pre-
senting with symptoms of pharyngitis, fever and elevated
markers of inflammation. The syndrome is characterised by
infectious thrombosis of the jugular vein due to infection
with Fusobacteria, causing a variety of infectious com-
plications. Rapid diagnosis and treatment is necessary to
avoid severe complications or death. Close collaboration
with local microbiologist is pivotal. Treatment consists of
longterm treatment with penicillin and metronidazole. This
is a case report of Lemierre’s syndrome.
Keywords Lemierre’s syndrome  Necrobacillosis 
Postanginal sepsis  Fusobacterium
Lemierre’s syndrome (LS, necrobacillosis, postanginal
sepsis) is a potentially fatal infection with septic vena
jugularis-thrombophlebitis. LS usually occurs in otherwise
healthy young subjects presenting a sudden drastic wors-
ening with sepsis after tonsillitis [1, 4, 5]. Here, we report a
young woman with LS with complications of multiple lung
abscesses, and affection of liver and spleen.
Case report
A 33-year old otherwise healthy woman was admitted to
our emergency department by her general practitioner. She
was suspected of having pneumonia after 5 days of sore
throat, cephalgia and a fever up to 40 C. Before admis-
sion, she was tested antigen-negative twice for hemolytic
Streptococcus group A and for EBV infection.
At admission (day 1), she suffered from dizziness, tin-
nitus, shortness of breath and a dry cough. She presented
with cold sweats, but all vital parameters were stable and
normal (tp. 36, 6, O2-saturation 99 % without oxygen,
respiratory frequence 18/min, blood pressure of 105/51
mmHg), except a regular heart rate without murmurs, fre-
quence 107 bpm. Paraclinical values: thrombocytes 37 9
109 (normal 150–400) and CRP 366 mg/L (\10; see Fig. 1),
as well as alkaline phosphatase 188 U/L (35–105) and bil-
irubin 57 lmol/L (5–25), along with increased creatinine
205 lmol/L (50–90).
Cholangitis was suspected and intravenous cefuroxime,
gentamycin and metronidazole were initiated after blood cul-
tures. Abdominal ultrasonography (day 2) showed splenom-
egali, but otherwise without abnormal findings.
Anaerobic blood cultures showed growth of Fusobac-
terium necrophorum (day 4). Antibiotics were switched to
iv penicillin and metronidazole. Transthoracal echocardi-
ography showed no signs of endocarditis. A CT-scan of the
head, neck and thorax showed a 9 cm long thrombosis in
the internal jugular vein as well as multiple lung abscesses,
largest of volume in the middle lobe (Fig. 2). Warfarin was
commenced on day 4, but paused day 6 due to haemopt-
ysis. Clinical and paraclinical improvement on antibiotics
was observed (Fig. 1). Day 17, a new CT-scan was per-
formed, showing remission of lung abscesses, but pro-
gression of the thrombosis. Fragmin 200 IE/kg/day was
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re-inserted with transition to warfarin on day 22 without
haemoptysis. On day 26, the patient was discharged with a
follow-up after 3 weeks of oral phenoxymethylpenicillin 1
MIE 9 4 and metronidazole 500 mg 9 3, as well as
3 months of Warfarin treatment (INR-target 2–3). Ultra-
sound of the veins of the neck on day 46 showed complete
remission of the thrombus in the internal jugular vein. She
was followed up on day 90 (chest X-ray: satisfactory
regression of the middle lobe infiltrate), and without LS-
recurrence since then (17 months as of now).
Discussion
Lemierre’s syndrome is seen after tonsillitis, pharyngitis or
dental infection, facilitating a local invasion of Fusobac-
terium, most often Fusobacterium necrophorum, in the
pharyngeal space or the internal jugular vein, where the
infection causes septic thrombophlebitis. This occurs
within 1–3 weeks. LS is often complicated by a hemato-
geneous spread, typically to lungs and larger joints, skin,
liver, spleen, heart and CNS [5].
Karkos et al. [5] found that F. necrophorum was the
cause of 10% of all throat infections (21 % of recurrent
infections), but the frequency of LS remains largely
unknown [4]. An increase has been reported since the
1990s [2, 4]. Untreated, the mortality reaches 17 %, and
even with treatment mortality is still significant, especially
with meningitis [2, 3]. In the Nordic countries, a combi-
nation of (initially intravenous) penicillin and metronida-
zole for a minimum of 3 weeks is recommended.
Development of resistance is rare [2, 4, 5].
Anticoagulation remains controversial, and without any
consensus [4, 5]. In this case report, progression of the
thromb was seen despite 17 days of relevant antibiotic
treatment.
In children, Fusobacterium infection is often seen with
otitis media. In the elderly, Fusobacterium infection with a
focus caudal of the head is more common, and often in
Fig. 1 Progression of CRP and
thrombocytes during treatment
Fig. 2 Sagittal CT with contrast: white thin arrows thrombosis in
vena jugularis interna dexter. Fat yellow arrow abscess in the right
posterior lobe
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relationship with cancer [2]. Infection in these last men-
tioned has a higher mortality, up to 25 %.
Conclusion
Lemierre’s syndrome should be considered in otherwise
healthy young subjects with development of sepsis after a
recent tonsillitis or pharyngitis. Anaerobe blood culture is
crucial for achieving diagnosis. Antibiotics effectively
reduce mortality. Addition of anticoagulation is subject to
debate, and currently the need is assessed by the clinical
picture and imaging.
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